Eric Carlson

USPTO Granted Patents = 15 (Patent Applications = 2)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 251(Granted Patents)

Location History:

Ketchum, ID (US) (2011 - 2018)
Portland, OR (US) (2014 - 2020)
Merrimack, NH (US) (2010 - 2021)

Company Filing History:

7 out of 527

Eisai R&d Management Co., Ltd.

Shriners Hospital for Children

patents

Years Active: 2010-2021

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11130758 - Tetrahydropyrazolopyrimidine compounds (2021-09-28),

2. 10642071 - Tinted polarized lenses having selective frequency filtering (2020-05-05),

3. 10640500 - Tetrahydropyrazolopyrimidine compounds (2020-05-05),

4. D849826 - Eyerwear (2019-05-28),

5. 9891448 - Tinted polarized lenses having selective frequency filtering (2018-02-13),

6. 9857380 - Profiling fragments of elastic fibers and microfibrils as biomarkers for disease (2018-01-02),

7. 9850242 - Tetrahydropyrazolopyrimidine compounds (2017-12-26),

8. 9446046 - Tetrahydropyrazolopyrimidine compounds (2016-09-20),

9. 9428495 - Selectively substituted quinoline compounds (2016-08-30),

10. 9126999 - Tetrahydropyrazolopyrimidine compounds (2015-09-08),

11. 8675452 - Systems and methods for timing athletic events (2014-03-18),

12. D654628 - Helmet (2012-02-21),

13. D650132 - Helmet (2011-12-06),

14. D645210 - Helmet (2011-09-13),

15. 7666875 - Hydantoin compounds (2010-02-23),

Title: The Innovative Contributions of Eric Carlson

Introduction

Eric Carlson is a prominent inventor based in Portland, OR (US), known for his significant contributions to the field of pharmaceuticals. With a total of 15 patents to his name, Carlson has made remarkable strides in developing compounds that address critical health issues.

Latest Patents

Among his latest innovations are the tetrahydropyrazolopyrimidine compounds. These compounds serve as antagonists or inhibitors for Toll-like receptors 7 and/or 8. They are particularly noteworthy for their potential use in pharmaceutical compositions aimed at treating systemic lupus erythematosus (SLE) and lupus nephritis.

Career Highlights

Throughout his career, Eric Carlson has worked with notable companies such as Eisai R&D Management Co., Ltd. and Smith Optics, Inc. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Carlson has collaborated with several professionals in his field, including Shawn Schiller and Hans J Hansen. These partnerships have fostered an environment of creativity and innovation, leading to the development of impactful solutions in healthcare.

Conclusion

Eric Carlson's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the development of tetrahydropyrazolopyrimidine compounds, highlight the importance of research and collaboration in addressing complex health challenges.

This text is generated by artificial intelligence and may not be accurate.